KLF2 INDUCING DEUTERATED COMPOUNDS AND USES THEREOF

Number of patents in Portfolio can not be more than 2000

United States of America

APP PUB NO 20250109143A1
SERIAL NO

18792742

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure provides deuterated compounds that are inducers of KLF2 and pharmaceutical compositions comprising the same. The present disclosure further provides method of treating an inflammatory disease or endothelial dysfunction comprising administering a therapeutically effective amount of the deuterated compounds disclosed herein.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
RIPARIAN PHARMACEUTICALS INCWATERTOWN MA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Serrano-Wu, Michael Boston, US 14 256
Tuttle, Jamison Bryce Marblehead, US 20 7
Wester, Ronald T Ledyard, US 37 688

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation